Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

NCT03223961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS

NCT04573686 ·Status: UNKNOWN

Treatment of Chronic Anemia With Epoetin Alfa in Elderly

NCT00337441 ·Status: UNKNOWN ·Phase: PHASE2

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

NCT02860598 ·Status: UNKNOWN

A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies

NCT00210977 ·Status: WITHDRAWN

Apotransferrin in Atransferrinemia

NCT01797055 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment

NCT00211042 ·Status: COMPLETED

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

NCT02608060 ·Status: TERMINATED ·Phase: PHASE4

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

NCT00443339 ·Status: UNKNOWN ·Phase: PHASE2

Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

NCT00398749 ·Status: COMPLETED

A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

NCT00776425 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)

NCT00924781 ·Status: TERMINATED ·Phase: PHASE2

" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

NCT06983756 ·Status: NOT_YET_RECRUITING

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

NCT00145652 ·Status: COMPLETED ·Phase: PHASE3

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

The Role of Erythropoietin in Myelodysplastic Syndrome

NCT00723112 ·Status: COMPLETED

High Dose of Erythropoietin Analogue After Cardiac Arrest

NCT00999583 ·Status: COMPLETED ·Phase: PHASE3

Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients

NCT01548495 ·Status: UNKNOWN

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

NCT00077597 ·Status: COMPLETED ·Phase: PHASE3

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT06499285 ·Status: RECRUITING ·Phase: PHASE3

A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia

NCT00090753 ·Status: COMPLETED ·Phase: PHASE3

Treatment Program for Anemia in AIDS Patients

NCT00002022 ·Status: COMPLETED ·Phase: NA

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

NCT02731378 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

NCT02767765 ·Status: COMPLETED ·Phase: PHASE3

Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease

NCT00579046 ·Status: WITHDRAWN ·Phase: PHASE3